In vivo antiaggregatory action of platelet-activating factor in beagle dogs: Role for prostacyclin

F. Herman, K. Magyar, J. G. Filep

Research output: Contribution to journalArticle

2 Citations (Scopus)


The effects of platelet-activating factor (PAF) on in vivo platelet aggregation were studied in anaesthetized beagle dogs by using the extracorporeal filter-loop technique. Intraarterial administration of PAF caused an immediate increase in filter pressure, indicating enhanced in vivo platelet aggregation. Intravenous administration of PAF (3-100 ng kg-1) resulted in a transient dose-dependent inhibition of spontaneous platelet aggregation on the filter with concomitant elevation in plasma 6-keto-PGF(1α) levels. These changes were significantly attenuated by pretreatment of the animals either with BN 52021 (4 mg kg-1), a specific PAF receptor antagonist or with acetylsalicylic acid (25 mg kg-1). Intraarterial infusion of exogenous prostacyclin at concentrations similar to those observed following intravenous PAF administration, resulted in a transient inhibition of the spontaneous platelet aggregation. These data provide evidence for prostacyclin release in response to PAF, and suggest that prostacyclin may mediate the in vivo anti-aggregatory action of PAF in anaesthetized dogs.

Original languageEnglish
Pages (from-to)296-299
Number of pages4
JournalThrombosis and Haemostasis
Issue number3
Publication statusPublished - Jan 1 1991


ASJC Scopus subject areas

  • Hematology

Cite this